Lignin blockers and uses thereof
    123.
    发明申请
    Lignin blockers and uses thereof 有权
    木质素阻滞剂及其用途

    公开(公告)号:US20060088922A1

    公开(公告)日:2006-04-27

    申请号:US11229817

    申请日:2005-09-19

    CPC classification number: C12P7/10 C12P7/08 C12P19/02 Y02E50/16 Y02E50/17

    Abstract: Disclosed is a method for converting cellulose in a lignocellulosic biomass. The method provides for a lignin-blocking polypeptide and/or protein treatment of high lignin solids. The treatment enhances cellulase availability in cellulose conversion and allows for the determination of optimized pretreatment conditions. Additionally, ethanol yields from a Simultaneous Saccharification and Fermentation process are improved 5-25% by treatment with a lignin-blocking polypeptide and/or protein. Thus, a more efficient and economical method of processing lignin containing biomass materials utilizes a polypeptide/protein treatment step that effectively blocks lignin binding of cellulase.

    Abstract translation: 公开了一种在木质纤维素生物质中转化纤维素的方法。 该方法提供高木质素固体的木质素阻断多肽和/或蛋白质处理。 该处理增强了纤维素转化中的纤维素酶可用性,并且允许确定优化的预处理条件。 此外,通过用木质素阻断多肽和/或蛋白质处理,来自同时糖化和发酵过程的乙醇产率提高了5-25%。 因此,处理含木质素的生物质材料的更有效和经济的方法利用有效阻断木质素结合纤维素酶的多肽/蛋白质处理步骤。

    Automatic frequency correction for mobile radio receivers

    公开(公告)号:US07016404B2

    公开(公告)日:2006-03-21

    申请号:US10379988

    申请日:2003-03-05

    Applicant: Bin Yang

    Inventor: Bin Yang

    CPC classification number: H04L27/2332 H04L2027/0065

    Abstract: A device and a method for automatic frequency correction are used in mobile radio receivers. After channel estimation has been performed, the phases of the received data symbols are analyzed in order to determine the frequency shift. Following the phase analysis, a phase correction of the received data symbols is performed.

    Glucagon antagonists
    129.
    发明授权
    Glucagon antagonists 有权
    胰高血糖素拮抗剂

    公开(公告)号:US08981047B2

    公开(公告)日:2015-03-17

    申请号:US12739342

    申请日:2008-10-23

    CPC classification number: C07K14/605 A61K38/00

    Abstract: Glucagon antagonists are provided which comprise amino acid substitutions and/or chemical modifications to glucagon sequence. In one embodiment, the glucagon antagonists comprise a native glucagon peptide that has been modified by the deletion of the first two to five amino acid residues from the N-terminus and (i) an amino acid substitution at position 9 (according to the numbering of native glucagon) or (ii) substitution of the Phe at position 6 (according to the numbering of native glucagon) with phenyl lactic acid (PLA). In another embodiment, the glucagon antagonists comprise the structure A-B-C as described herein, wherein A is PLA, an oxy derivative thereof, or a peptide of 2-6 amino acids in which two consecutive amino acids of the peptide are linked via an ester or ether bond.

    Abstract translation: 提供了包含对胰高血糖素序列的氨基酸取代和/或化学修饰的胰高血糖素拮抗剂。 在一个实施方案中,胰高血糖素拮抗剂包含通过从N-末端缺失前两个至五个氨基酸残基而修饰的天然胰高血糖素肽,以及(i)在第9位的氨基酸取代(根据 天然胰高血糖素)或(ii)用苯基乳酸(PLA)取代第6位的Phe(根据天然胰高血糖素的编号)。 在另一个实施方案中,胰高血糖素拮抗剂包含如本文所述的结构ABC,其中A是PLA,其氧衍生物或2-6个氨基酸的肽,其中肽的两个连续氨基酸经由酯或醚连接 键。

Patent Agency Ranking